Skip to main navigation Skip to search Skip to main content

Verminderde afweer: Risicogroepen en gevolgen voor de huisartsenpraktijk

Translated title of the contribution: Impaired immunity: Risk groups and consequences for general practice
  • Wim Opstelten*
  • , J. W J Hans Bijlsma
  • , Luc B S Gelinck
  • , C. M J Lian Hielkema
  • , Theo J M Verheij
  • , Willem Van Eden
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Due to medication use, comorbidities and/or age, an increasing number of patients have an impaired immunity to infection. Impaired immunity may lead to an increased risk of (opportunistic) infection, complications from infections, and difficulties in the diagnosis of infections. Guided by clinical parameters, a general practitioner can classify an impaired immunity as 'clinically irrelevant', 'limitedly relevant' or 'potentially serious'. Tocilizumab impairs the production of CRP, which makes it unreliable as an infection parameter. In case of a suspected infection in patients with severe immunosuppression, it will often be necessary to consult a specialist as quickly as possible about further diagnostic procedures and the need for, type and administration route of antimicrobials. In patients with an impaired immunity, adaptation of the antibiotic policy and prophylactic measures, such as vaccination, may be indicated. Patients with (functional) asplenia should immediately start antibiotic treatment in case of fever, pending clinical evaluation by a physician.

Translated title of the contributionImpaired immunity: Risk groups and consequences for general practice
Original languageDutch
Article numberA9752
Pages (from-to)1-8
Number of pages8
JournalNederlands Tijdschrift voor Geneeskunde
Volume160
Issue number22
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Impaired immunity: Risk groups and consequences for general practice'. Together they form a unique fingerprint.

Cite this